Entyvio Injection and Insulin aspart, recombinant Subcutaneous
Determining the interaction of Entyvio Injection and Insulin aspart, recombinant Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: vedolizumab
Brand name: Entyvio
Synonyms: Vedolizumab
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Entyvio Injection-Insulin degludec
- Entyvio Injection-Insulin Degludec (U-100) Prefilled Pens
- Entyvio Injection-Insulin Degludec (U-100) Vials
- Entyvio Injection-Insulin Degludec (U-200) Prefilled Pens
- Entyvio Injection-Insulin degludec and liraglutide
- Entyvio Injection-Insulin degludec and liraglutide Subcutaneous
- Insulin aspart, recombinant Subcutaneous-Enulose
- Insulin aspart, recombinant Subcutaneous-Envarsus XR
- Insulin aspart, recombinant Subcutaneous-Enzalutamide
- Insulin aspart, recombinant Subcutaneous-Enzoclear Foam
- Insulin aspart, recombinant Subcutaneous-Eolarix
- Insulin aspart, recombinant Subcutaneous-Eovist